An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device.
Authors
Henry, Ann MStratford, Julia
Davies, Julie
McCarthy, Claire
Swindell, Ric
Sykes, Jonathan R
Moore, Christopher J
Price, Patricia M
Khoo, Vincent S
Affiliation
Academic Department of Radiation Oncology, University of Manchester, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK.Issue Date
2005-08
Metadata
Show full item recordAbstract
Verification of target organ position is essential for the accurate delivery of conformal radiotherapy. Megavoltage electronic portal imaging with flat panel amorphous silicon detectors delivers high quality images that can be used for verification of bony landmark position. Gold markers implanted into the target organ can be visualized and used as a surrogate of actual organ position. On-line compensation for marker displacement, by adjusting patient position, can reduce geometric errors associated with radiation delivery. This study assesses the optimal marker length and diameter to be used with an amorphous silicon (a-Si) flat panel detector and electronic portal images (EPIs), prior to implementation of a clinical programme of gold marker insertion in prostate cancer patients. Seven marker sizes varying from 3 mm to 8 mm in length and 0.8 mm to 1.1 mm in diameter were investigated in a group of patients undergoing pelvic radiotherapy using an 8 MV Elekta SL20 linear accelerator. Markers were placed on the skin entry and exit sites of the treatment beam and EPIs in both lateral and anterior pelvic views were acquired. Three observers independently assessed visibility success and failure using a subjective scoring system. Markers less than 5 mm in length or 0.9 mm in diameter were poorly visualized (<70% visualization success in lateral EPIs). The marker measuring 0.9 mm x 5 mm appears to be clinically optimal in pelvic radiotherapy patients (80% visualization success in lateral EPIs) and will be used for actual organ implantation.Citation
An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. 2005, 78 (932):737-41 Br J RadiolJournal
The British Journal of RadiologyDOI
10.1259/bjr/97956788PubMed ID
16046426Type
ArticleLanguage
enISSN
0007-1285ae974a485f413a2113503eed53cd6c53
10.1259/bjr/97956788
Scopus Count
Collections
Related articles
- Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK).
- Authors: Nederveen A, Lagendijk J, Hofman P
- Issue date: 2000 Jul 15
- Feasibility of automatic marker detection with an a-Si flat-panel imager.
- Authors: Nederveen AJ, Lagendijk JJ, Hofman P
- Issue date: 2001 Apr
- Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
- Authors: Schallenkamp JM, Herman MG, Kruse JJ, Pisansky TM
- Issue date: 2005 Nov 1
- The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI).
- Authors: Owen R, Kron T, Foroudi F, Cox J, Zhu L, Cramb J, Sparks L, Duchesne G
- Issue date: 2008 Autumn
- Consistency in electronic portal imaging registration in prostate cancer radiation treatment verification.
- Authors: Berthelet E, Truong PT, Zavgorodni S, Moravan V, Liu MC, Runkel J, Bendorffe B, Sayers D
- Issue date: 2006 Sep 19